Picture of INIFY Laboratories AB logo

INIFY INIFY Laboratories AB Share Price

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-23.93%
3m-24.2%
6m-38.13%
1yr+17.25%
Volume Change (%)
10d/3m+244.03%
Price vs... (%)
52w High-40.59%
50d MA-16.08%
200d MA-17.47%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value4.5
Price to Tang. Book4.83
Price to Free Cashflown/a
Price to Sales1,095.22
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-46.71%
Return on Equity-37.68%
Operating Margin-12160.15%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of INIFY Laboratories AB EPS forecast chart

Profile Summary

INIFY Laboratories AB is a Sweden-based medical research company that provides cancer diagnostics through laboratory services within pathology. The Company uses a fully digital, standardized and Artificial Intelligence (AI)- supported workflow to optimize quality and response times, initially within prostate. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. INIFY Laboratories' laboratory in Solna, Sweden is intended to provide two types of analyses of prostate Biopsy Specimens to clients: Full pathology Report signed by an INIFY subspecialized pathologist and Whole Slide Images (WSI) generation and result of Pathology Decision Support Tool (PDST) analysis only. The Company origins from ContextVision.

Directors

    Last Annual
    December 31st, 2022
    Last Interim
    September 30th, 2023
    Incorporated
    November 10th, 2021
    Public Since
    June 20th, 2022
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    no flag iconOslo Stock Exchange
    Shares in Issue
    45,236,750

    INIFY Share Price Performance

    Upcoming Events for INIFY

    INIFY Laboratories AB Annual Shareholders Meeting

    Similar to INIFY

    Picture of Codelab Capital AS logo

    Codelab Capital AS

    no flag iconOslo Stock Exchange

    Picture of ContextVision AB logo

    ContextVision AB

    no flag iconOslo Stock Exchange

    Picture of Gentian Diagnostics ASA logo

    Gentian Diagnostics ASA

    no flag iconOslo Stock Exchange

    Picture of Medistim ASA logo

    Medistim ASA

    no flag iconOslo Stock Exchange

    Picture of Nordhealth AS logo

    Nordhealth AS

    no flag iconOslo Stock Exchange

    FAQ